Pint Pharma has announced that COFEPRIS in Mexico has approved ORLADEYO (berotra...
The UK NHS has introduced Pfizer's tafamidis for transthyretin amyloidosis cardi...
The approval was supported by the TRIDENT-1 trial studying Augtyro in TKI-naïve ...
Almost 12 months after the South American Summit, advancing pharma trade and rai...
Shionogi has concluded an exclusive global licence agreement for Maze Therapeuti...
Tabuk obatined rights to commercialise Formosacs l'obetasol propionate ophthalmi...
GlobalData examines four of the key trends affecting contract research organizat...
Attovia Therapeutics has secured $105m in a Series B financing round to expedite...
Novo Nordisk has entered into a deal with Flagship Pioneering and Metaphore Biot...
Sanofi has signed a $1.2bn licensing agreement with Novavax to co-commercialise ...
RAPT is closing two Phase II trials for Rapt’s lead candidate, zelnecirnon, thre...
The positive Phase I/II data has supported a RMAT designation from the FDA and a...
The FDA has given an IND approval for WestGene’s mRNA therapeutic cancer vaccine...
Discover key insights into the selection of oral solid dosage manufacturing comp...
The US FDA has granted fast track designation for iECURE’s ECUR-506 for the trea...
AstraZeneca has begun the global withdrawal of its Covid-19 vaccine Vaxzevria, c...
